CVS faces significant 2025 headwinds, including intense pharmacy competition, threatened new federal government pressures, excessive leverage/debt, plus

CVS Health's poor 2024 performance could be turning around in 2025 with a new CEO and potential rebound, despite challenges. Read my analysis of CVS stock here.

We recently published a list of 12 Best Fortune 500 Dividend Stocks To Buy Right Now. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against other best Fortune 500 dividend stocks to buy right now.

CVS Health shares are trading lower by 2.7% during Thursday's session. Shares of insurers and pharmacy benefit manager stocks are trading lower in possible reaction to UnitedHealth's quarterly revenue miss.

CVS Health ( CVS 4.35%) is a stock that's been struggling badly for multiple years and is coming off a brutal performance in 2024, when its shares nose-dived by 43%.

CVS Health has disclosed plans to lay off another 13 employees who are based at or report to its offices at 151 Farmington Ave., in Hartford.

We recently published a list of 10 Firms Dominate Monday Upsurge. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against other firms that dominated Monday upsurge.

This week's dividend activity included increased payouts from Lakeland Financial (LKFN) and Valero Energy (VLO) as well as declarations from companies such as Citigroup (NYSE:C) and Procter & Gamble (NYSE:PG).

Shares of CVS Health Corp. CVS advanced 1.11% to $52.14 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.83% to 5,949.91 and the Dow Jones Industrial Average DJIA rising 1.

CVS Health's Medicaid business is experiencing medical cost pressure from higher-than-expected acuity following the resumption of member redeterminations.

If Oz is confirmed by the U.S. Senate, he'll immediately lead an agency that provides health care for 160 million Americans via Medicaid, Medicare and other programs. Oz would also run the U.S. Affordable Care Act exchanges, which saw 24 million Americans enroll in government-sponsored health care plans in 2024.

The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from price gouging.